Caplin Point Laboratories informs about press release

03 Mar 2023 Evaluate
Caplin Point Laboratories has informed that it enclosed Press Release regarding grant of USFDA approval for its Abbreviated New Drug Application (ANDA) Rocuronium Bromide Injection to its Subsidiary Caplin Steriles.

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

1813.45 26.10 (1.46%)
31-Dec-2025 09:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1721.90
Dr. Reddys Lab 1262.60
Cipla 1495.00
Zydus Lifesciences 908.95
Lupin 2083.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×